Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local budesonide nasal irrigation for persistent hyposmia in non-severe COVID-19
2020-001667-85Phase 3Completed
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of budesonide in Hyposmia and coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Adolphe de Rothschild Foundation Hospital. Started Apr 2020; status: completed.
02
Drugs
budesonide
03
Conditions
Hyposmiacoronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001667-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001667-85.